Thoughts on the Upadacitinib Clinical Trial for Lupus Patients
I'm curious to hear your thoughts on the study titled 'Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Patients With Moderate to Severe Lupus'. This phase III trial aims to evaluate the safety and efficacy of Upadacitinib, an oral JAK1 inhibitor, in pati...